Current role
Brian J. Caveney, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian J. Caveney, M.D.
Labcorp Holdings Inc. reported in an 8-K filed August 14, 2026 that Brian J. Caveney, M.D. was appointed Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer, effective September 1, 2026.
“Effective September 1, 2026, Brian J. Caveney, M.D., the current Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer of the Company, will assume the role of Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer, with responsibility for the Company's Early Development Research Laboratories and Central Laboratories businesses.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Labcorp Holdings Inc. (LH)
SEC 8-K
Current2026-09-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Labcorp Holdings Inc.
Other people whose current roles at this company are on record from its filings.
- DAVID P. KING CEO
- JOHN D. RATLIFF CEO
- PAUL R. KIRCHGRABER CEO
- Thomas (Tom) Pike CEO, Chairman
- Julia Wang CFO
- MARK S. SCHROEDER COO
- Adam Schechter Board Member
- Garheng Kong Board Member
- JEFFREY A. DAVIS Board Member
- John H. Sampson, M.D., Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.